Market Cap 7.08B
Revenue (ttm) 10.90M
Net Income (ttm) -322.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,956.88%
Debt to Equity Ratio 0.00
Volume 1,269,600
Avg Vol 2,697,298
Day's Range N/A - N/A
Shares Out 145.90M
Stochastic %K 54%
Beta 0.97
Analysts Strong Sell
Price Target $68.31

Company Profile

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stag...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 401 7900
Address:
10578 Science Center Drive, Suite 125, San Diego, United States
Jhane13
Jhane13 Oct. 25 at 2:58 AM
$RNA Congratulations to all the longs.
0 · Reply
StockProph3t
StockProph3t Oct. 22 at 6:58 AM
$RNA good feeling about a buyout here in the next week or two. Far too many times companies get approached and subsequently bought after offerings, bidding war perhaps? Who could other suitors Be? Roche BMY? I guess we wait and see. $85 should get this done. Regardless can’t see this staying public past November, Financial Times leak let all the big boys know they are for sale. GL to all!
0 · Reply
Jhane13
Jhane13 Oct. 21 at 7:26 PM
$RNA Congratulations to all the longs.
1 · Reply
wwmeinc
wwmeinc Oct. 21 at 3:25 PM
$RNA ...Chardan on tap today....their target is $75. Buy low sell high still in play...but to each our own...good trading and glta. Chardan 9th Annual Genetic Medicines Conference, New York, NYTuesday, October 21, 2025, at 11:00 a.m. PT / 2:00 p.m. ET https://stockanalysis.com/analysts/keay-nakae/
0 · Reply
Jhane13
Jhane13 Oct. 20 at 4:54 PM
$RNA Congratulations to all the longs, this might be @ 83 soon.
1 · Reply
Stockswingalert
Stockswingalert Oct. 20 at 12:06 PM
$PRQR $RNA $RNAC $WVE $XBI https://www.stocktitan.net/news/PRQR/pro-qr-receives-cta-authorization-for-ax-0810-and-announces-virtual-4b4910ofj7dt.html
1 · Reply
Jhane13
Jhane13 Oct. 17 at 4:33 PM
$RNA Congratulations to all the longs, going to 75.
2 · Reply
wwmeinc
wwmeinc Oct. 17 at 2:55 PM
$RNA ....Citi slapped a $75....price 'target' on us yesterday....looks good to me....being the 'calm and patient' type et al...;) Hmmm....ok...Rome was not built in one month...or two or three....and with Avidity, now that the FDA has presented the path forward for them to get their accelerated approval up and running...this is kind of going to be put in the hold and forget mode for awhile...but with an eye out for one of those wash-out mkt days that may arise before the Santa Rally kicks in....all short-term blips....Trump does like to see a green mkt so that might keep the bears away for awhile....Did notice the news blurp this morning regarding the $1.2T....T with a Trillion...that is now costing taxpayers in interest pymt's on the Nat'l debt of ~$37T ....that is alot of cash being paid to the debt holders. $RIOT $BTC.X glta "In a report released today, Geoff Meacham from Citi maintained a Buy rating on Avidity Biosciences, with a price target of $75.00. https://www.tipranks.com/news/blurbs/avidity-biosciences-rna-receives-a-buy-from-citi-blurbs?mod=mw_quote_news
0 · Reply
Stockswingalert
Stockswingalert Oct. 17 at 4:50 AM
0 · Reply
Stockswingalert
Stockswingalert Oct. 17 at 4:49 AM
0 · Reply
Latest News on RNA
Jhane13
Jhane13 Oct. 25 at 2:58 AM
$RNA Congratulations to all the longs.
0 · Reply
StockProph3t
StockProph3t Oct. 22 at 6:58 AM
$RNA good feeling about a buyout here in the next week or two. Far too many times companies get approached and subsequently bought after offerings, bidding war perhaps? Who could other suitors Be? Roche BMY? I guess we wait and see. $85 should get this done. Regardless can’t see this staying public past November, Financial Times leak let all the big boys know they are for sale. GL to all!
0 · Reply
Jhane13
Jhane13 Oct. 21 at 7:26 PM
$RNA Congratulations to all the longs.
1 · Reply
wwmeinc
wwmeinc Oct. 21 at 3:25 PM
$RNA ...Chardan on tap today....their target is $75. Buy low sell high still in play...but to each our own...good trading and glta. Chardan 9th Annual Genetic Medicines Conference, New York, NYTuesday, October 21, 2025, at 11:00 a.m. PT / 2:00 p.m. ET https://stockanalysis.com/analysts/keay-nakae/
0 · Reply
Jhane13
Jhane13 Oct. 20 at 4:54 PM
$RNA Congratulations to all the longs, this might be @ 83 soon.
1 · Reply
Stockswingalert
Stockswingalert Oct. 20 at 12:06 PM
$PRQR $RNA $RNAC $WVE $XBI https://www.stocktitan.net/news/PRQR/pro-qr-receives-cta-authorization-for-ax-0810-and-announces-virtual-4b4910ofj7dt.html
1 · Reply
Jhane13
Jhane13 Oct. 17 at 4:33 PM
$RNA Congratulations to all the longs, going to 75.
2 · Reply
wwmeinc
wwmeinc Oct. 17 at 2:55 PM
$RNA ....Citi slapped a $75....price 'target' on us yesterday....looks good to me....being the 'calm and patient' type et al...;) Hmmm....ok...Rome was not built in one month...or two or three....and with Avidity, now that the FDA has presented the path forward for them to get their accelerated approval up and running...this is kind of going to be put in the hold and forget mode for awhile...but with an eye out for one of those wash-out mkt days that may arise before the Santa Rally kicks in....all short-term blips....Trump does like to see a green mkt so that might keep the bears away for awhile....Did notice the news blurp this morning regarding the $1.2T....T with a Trillion...that is now costing taxpayers in interest pymt's on the Nat'l debt of ~$37T ....that is alot of cash being paid to the debt holders. $RIOT $BTC.X glta "In a report released today, Geoff Meacham from Citi maintained a Buy rating on Avidity Biosciences, with a price target of $75.00. https://www.tipranks.com/news/blurbs/avidity-biosciences-rna-receives-a-buy-from-citi-blurbs?mod=mw_quote_news
0 · Reply
Stockswingalert
Stockswingalert Oct. 17 at 4:50 AM
0 · Reply
Stockswingalert
Stockswingalert Oct. 17 at 4:49 AM
0 · Reply
ultraman905905
ultraman905905 Oct. 15 at 8:02 PM
$RNA @Jhane13 not congratulating the longs scare me
0 · Reply
ultraman905905
ultraman905905 Oct. 14 at 3:15 PM
$RNA @Jhane13 dumping his shares on us.
1 · Reply
wwmeinc
wwmeinc Oct. 14 at 2:48 PM
$RNA ...Low vol. this morning....Tip ranks now calling out the 'delay'....no matter....lots of macro issues around...Fed speak and US/China tit-for-tat speak seems to be giving way to a higher close though. Bessent complaining about the shutdown probably adds some pressure on the House "leader"....loose term really.... to get back into session....with our very bullish analyst calls here....support is sound....save for some off-base trader/hedge fund selling a few to make it seem as if the bottom is going to fall out with this 'delay'....I do not see that happening but then who forsaw the BLA delay nr yesterday? Gotta have conviction and optimism and of course, good timing in these mkt's nowadays....playing the long view ;) Just some thoughts as the days now tick down to that all important BLA filing....not to say if a drop does occur it will not be gobbled up very quickly....Good trading and glta https://whalewisdom.com/stock/rna
0 · Reply
StockProph3t
StockProph3t Oct. 14 at 2:09 PM
$RNA @Jhane13 you buying more?
2 · Reply
wwmeinc
wwmeinc Oct. 13 at 2:00 PM
$RNA ....Timing is always a 'gamble'....I, like others maybe, had 2025(late Q4) as the Co. has oftened stated...many times really...for their BLA submission....today they dropped the late 2025 and stated "early" 2026....not to say they spring a surprise, and actually do a 'late' 2025 BLA submission....as I said...timing is always a gamble....but as the science/data has been telling us...we have the goods! All is good for the pay-off here....in my opinion. glta "The timing for the BLA submission has been updated to Q1 2026 from previous guidance of year end 2025 to ensure the FDA receives additional data to support the chemistry, manufacturing, and controls (CMC) package at time of submission."
1 · Reply
StockProph3t
StockProph3t Oct. 12 at 12:34 PM
$RNA Late Breaking presentation uploaded. Functional Improvement ✅ Other exon skipping PMOs have not shown this consistency as early. Safe ✅ Clearly a de risked bet for any big buyer. Not sure how this stays public for long whether it’s Novartis or someone else. Plenty of buyouts happened after offering, Cerevel, Endocyte list goes on. https://www.aviditybiosciences.com/sites/default/files/2025-10/Veerapandiyan%20WMS%202025%20EXPLORE44%20Ambulation%20Subgroups%20Poster%20%281%29.pdf
0 · Reply
Jhane13
Jhane13 Oct. 10 at 8:49 PM
$RNA Congratulations to all the longs
3 · Reply
wwmeinc
wwmeinc Oct. 10 at 1:34 PM
$RNA ....another presentation on tap this Sat...Oct.11...Vienna,Austria "Delpacibart zotadirsen (del-zota) showed trends toward improvement in functional and patient-reported outcomes in individuals with DMD amenable to exon 44 skipping -- Oral presentation: Kevin M. Flanigan, M.D., Nationwide Children's Hospital, to present on October 11, 2025, from 12:33 - 12:45 p.m. CET -- Delpacibart Zotadirsen (Del-zota) Increased Dystrophin and Improved Muscle Integrity Markers Regardless of Ambulatory Status in Individuals with DMD44 -- Poster presentation (674P)." glta https://www.marketscreener.com/quote/stock/AVIDITY-BIOSCIENCES-INC-108225209/consensus/
0 · Reply
rockitpicks
rockitpicks Oct. 9 at 9:22 PM
$RNA Option activity heating up. Keeping a close eye on the 55.00 and 60.00 strike for a significant volume increase intraday. Clear options indicator was seen on AMD 5 days ago when option activity spiked 10x normal volume and stock ran from 205.00 to 240.00. Still expecting north of 80.00 in the near future.
0 · Reply
justanotherbull_
justanotherbull_ Oct. 9 at 7:43 PM
$RNA Congrats to all the longs!
0 · Reply
Stevej135
Stevej135 Oct. 9 at 7:37 PM
$RNA congrats all longs
0 · Reply
StockProph3t
StockProph3t Oct. 9 at 7:36 PM
$RNA congrats to the longs 😃
0 · Reply